Biomaterial Database

Acute renal failure associated with intraperitoneal cisplatin chemotherapy with systemic thiosulfate protection in ovarian cancer patients. 1991

J Menczer, and G Ben-Baruch, and S Rizel, and H Brenner

Department of Obstetrics, Gynecology, and Oncology, Sheba Medical Center, Tel Hashomer, Israel.

Acute renal failure associated with intraperitoneal cisplatin chemotherapy occurred in 4 courses of treatment each given to one patient, and comprised 3.4% of the total number of intraperitoneal treatment courses. The 4 patients recovered completely, 2 of them after dialysis. Several possible reasons for this complication, which occurred in spite of thiosulphate systemic protection, are considered. Strict adherence to the treatment protocol is mandatory in order to avoid severe nephrotoxicity.

UI	MeSH Term	Description	Entries
D007274	Injections, Intraperitoneal	Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall.	Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D010051	Ovarian Neoplasms	Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.	Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D002945	Cisplatin	An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle.	Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003404	Creatinine		Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D004334	Drug Administration Schedule	Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience.	Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013885	Thiosulfates	Inorganic salts of thiosulfuric acid possessing the general formula R2S2O3.	Thiosulfate
D058186	Acute Kidney Injury	Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.	Acute Kidney Failure,Acute Kidney Insufficiency,Acute Renal Failure,Acute Renal Injury,Acute Renal Insufficiency,Kidney Failure, Acute,Kidney Insufficiency, Acute,Renal Failure, Acute,Renal Insufficiency, Acute,Acute Kidney Failures,Acute Kidney Injuries,Acute Kidney Insufficiencies,Acute Renal Failures,Acute Renal Injuries,Acute Renal Insufficiencies,Kidney Failures, Acute,Kidney Injuries, Acute,Kidney Injury, Acute,Kidney Insufficiencies, Acute,Renal Failures, Acute,Renal Injuries, Acute,Renal Injury, Acute,Renal Insufficiencies, Acute

Related Publications

J Menczer, and G Ben-Baruch, and S Rizel, and H Brenner

Intraperitoneal cisplatin with systemic thiosulfate protection.

December 1982, Annals of internal medicine,

J Menczer, and G Ben-Baruch, and S Rizel, and H Brenner

Intraperitoneal high-dose cisplatin and etoposide with systemic thiosulfate protection in second-line treatment of advanced ovarian cancer.

May 1993, Gynecologic oncology,

J Menczer, and G Ben-Baruch, and S Rizel, and H Brenner

Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection.

March 1983, Cancer research,

J Menczer, and G Ben-Baruch, and S Rizel, and H Brenner

[Intraperitoneal cisplatin chemotherapy for ovarian cancer].

December 2001, Gan to kagaku ryoho. Cancer & chemotherapy,

J Menczer, and G Ben-Baruch, and S Rizel, and H Brenner

Sodium thiosulfate protects from renal impairement following hyperthermic intraperitoneal chemotherapy (HIPEC) with Cisplatin.

January 2020, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group,

J Menczer, and G Ben-Baruch, and S Rizel, and H Brenner

Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer.

March 2023, Cancer chemotherapy and pharmacology,

J Menczer, and G Ben-Baruch, and S Rizel, and H Brenner

Intraoperative intraperitoneal chemotherapy with cisplatin in epithelial ovarian cancer.

April 2012, Journal of gynecologic oncology,

J Menczer, and G Ben-Baruch, and S Rizel, and H Brenner

Intraperitoneal cisplatin with sodium thiosulfate protection in rats with intestinal anastomoses.

April 1993, Journal of surgical oncology,

J Menczer, and G Ben-Baruch, and S Rizel, and H Brenner

Population pharmacokinetics of cisplatin in patients with advanced ovarian cancer during intraperitoneal hyperthermia chemotherapy.

January 2002, Anticancer research,